Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.
D000818:Animals; D000941:Antigens; D002859:Chromium Isotopes; D002999:Clone Cells / Q000032:analysis; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D066298:In Vitro Techniques; D007518:Isoantibodies; D008074:Lipoproteins; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism; D012334:RNA, Neoplasm / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000276:immunology; D013154:Spleen / Q000276:immunology
D000941:Antigens; D002859:Chromium Isotopes; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007518:Isoantibodies; D008074:Lipoproteins; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D003609:Dactinomycin; D003513:Cycloheximide